These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71. The Association Between Serum Human Epididymis Protein 4 Level and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease. Lin H; Xiao J; Su X; Song B Lab Med; 2021 May; 52(3):260-266. PubMed ID: 33009814 [TBL] [Abstract][Full Text] [Related]
72. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. Frei A; Muggensturm P; Putcha N; Siebeling L; Zoller M; Boyd CM; ter Riet G; Puhan MA J Clin Epidemiol; 2014 Aug; 67(8):904-11. PubMed ID: 24786594 [TBL] [Abstract][Full Text] [Related]
73. [Cardiovascular comorbidity in COPD]. Cataluña JJ; García MA Arch Bronconeumol; 2009; 45 Suppl 4():18-23. PubMed ID: 20116745 [TBL] [Abstract][Full Text] [Related]
74. Subclinical cardiovascular disease in patients with chronic obstructive pulmonary disease: a systematic review. Ye C; Younus A; Malik R; Roberson L; Shaharyar S; Veledar E; Ahmad R; Ali SS; Latif MA; Maziak W; Feiz H; Aneni E; Nasir K QJM; 2017 Jun; 110(6):341-349. PubMed ID: 27539486 [TBL] [Abstract][Full Text] [Related]
75. Impact Of Peak Oxygen Pulse On Patients With Chronic Obstructive Pulmonary Disease. Wu CW; Hsieh PC; Yang MC; Tzeng IS; Wu YK; Lan CC Int J Chron Obstruct Pulmon Dis; 2019; 14():2543-2551. PubMed ID: 31819392 [TBL] [Abstract][Full Text] [Related]
76. Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues. Andrus MR; Loyed JV Drugs Aging; 2008; 25(2):131-44. PubMed ID: 18257600 [TBL] [Abstract][Full Text] [Related]
77. [Comorbidity of Chronic Obstructive Pulmonary Disease and Cardiovascular Diseases: Place of Therapy with Modern β-Adrenoblockers]. Belenkov YN; Tsvetkova OA; Privalova EV; An GV; Ilgisonis IS; Voronkova OO Kardiologiia; 2019 Jun; 59(6):48-55. PubMed ID: 31242841 [TBL] [Abstract][Full Text] [Related]
78. COPD in chronic heart failure: less common than previously thought? Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385 [TBL] [Abstract][Full Text] [Related]
79. Cardiovascular risk assessment, cardiovascular disease risk factors, and lung function parameters. Polak M; Doryńska A; Szafraniec K; Pająk A Kardiol Pol; 2018; 76(7):1055-1063. PubMed ID: 29399756 [TBL] [Abstract][Full Text] [Related]
80. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Wijnant SRA; De Roos E; Kavousi M; Stricker BH; Terzikhan N; Lahousse L; Brusselle GG Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31601717 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]